Blar i Department of Clinical Dentistry på tidsskrift "Frontiers in Pharmacology"
Viser treff 1-1 av 1
-
Decitabine-induced DNA methylation-mediated transcriptomic reprogramming in human breast cancer cell lines; the impact of DCK overexpression
(Journal article; Peer reviewed, 2022)Decitabine (DAC), a DNA methyltransferase (DNMT) inhibitor, is tested in combination with conventional anticancer drugs as a treatment option for various solid tumors. Although epigenome modulation provides a promising ...